Home/Filings/4/0001437749-19-012577
4//SEC Filing

PROVENZANO JOSEPH L 4

Accession 0001437749-19-012577

CIK 0000880242other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 5:22 PM ET

Size

20.6 KB

Accession

0001437749-19-012577

Insider Transaction Report

Form 4
Period: 2019-06-18
PROVENZANO JOSEPH L
DirectorSecretary and V.P. Operations
Transactions
  • Award

    Option to Purchase Common Stock

    2019-06-18$0.17/sh+1,000,000$170,0001,926,203 total
    Exercise: $0.17From: 2020-05-28Exp: 2029-05-28Common stock (1,000,000 underlying)
  • Award

    Common stock

    2019-06-18+500,0001,770,743 total
Footnotes (4)
  • [F1]Reporting Person and Issuer entered into an employment agreement on June 18, 2019. The agreement was effective as of May 28, 2019, as on that date Issuer's Compensation Committee met and awarded Reporting Person the restricted common stock and option reported on this Form 4. These securities were issued pursuant to Issuer's 2018 Equity Incentive Plan, and per the terms of the plan, the grant date of awards is the date granted by the Compensation Committee.
  • [F2]Issuer's Compensation Committee awarded the restricted common stock as an incentive to Reporting Person to enter into a five-year employment agreement. No other consideration was paid by Reporting Person for the issuance of the restricted common stock. Issuer's common stock closed at $0.17 on the May 28, 2019 grant date.
  • [F3]The Option vests in increments of 200,000 shares beginning on May 28, 2020, and each May 28th thereafter, until fully vested, and only if Reporting Person remains employed by Issuer.
  • [F4]The exercise price is based on the closing price of Issuer's common stock on the May 28, 2019 award date. See Footnote 1.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001252962

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 5:22 PM ET
Size
20.6 KB